Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less.
Adamo M, Fiorina C, Petronio AS, Giannini C, Tamburino C, Barbanti M, Bedogni F, Testa L, Colombo A, Latib A, Bruschi G, Reimers B, Poli A, Nazzaro MS, Curello S, Ettori F. Adamo M, et al. Among authors: nazzaro ms. Am J Cardiol. 2018 Nov 15;122(10):1718-1726. doi: 10.1016/j.amjcard.2018.08.006. Epub 2018 Aug 21. Am J Cardiol. 2018. PMID: 30227961
Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial.
Violini R, Musto C, De Felice F, Nazzaro MS, Cifarelli A, Petitti T, Fiorilli R. Violini R, et al. Among authors: nazzaro ms. J Am Coll Cardiol. 2010 Feb 23;55(8):810-4. doi: 10.1016/j.jacc.2009.09.046. J Am Coll Cardiol. 2010. PMID: 20170821 Free article. Clinical Trial.
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial.
Ferrante G, Presbitero P, Corrada E, Campo G, Bolognese L, Vassanelli C, Colangelo S, De Cesare N, E Rodriguez A, Bramucci E, Moreno R, Piva T, Sheiban I, Pasquetto G, Prati F, Nazzaro MS, Ferrari R, Valgimigli M. Ferrante G, et al. Among authors: nazzaro ms. Am Heart J. 2012 Jan;163(1):104-11. doi: 10.1016/j.ahj.2011.09.026. Am Heart J. 2012. PMID: 22172443 Clinical Trial.
55 results